Perpetual Futures Funding-Rate Engine: Architecture (2026)
A 2026 systems design for a perpetual futures funding-rate engine: index/mark price, premium aggregation, settlement scheduling, and failure modes.
OpenBao Secrets Management: A Production Tutorial (2026)
A 2026 production tutorial for OpenBao secrets management: sealing, auth methods, dynamic secrets, Kubernetes injection, and high-availability deployment.
Valkey vs Redis vs Dragonfly: In-Memory Store ADR (2026)
An architecture decision record comparing Valkey, Redis, and Dragonfly in 2026: licensing, clustering, throughput, memory model, and when to pick each.
Text-to-SQL LLM Benchmark: Accuracy and Latency (2026)
A 2026 text-to-SQL benchmark methodology: execution accuracy, schema linking, latency, and cost across model tiers - plus where generated SQL goes wrong.
LLM Prompt Caching: Architecture and Economics (2026)
How LLM prompt caching works in 2026: provider-side vs self-hosted KV reuse, cache-aware prompt design, hit-rate economics, and where it quietly breaks.
NVIDIA at Hannover Messe 2026: AI Digital Twins Analyzed
An analysis of NVIDIA's AI-driven manufacturing showcase at Hannover Messe 2026: what the Omniverse digital twin stack means for real factory builds.
FMI 3.0 Co-Simulation with FMPy: A Hands-On Tutorial
A hands-on 2026 tutorial for FMI 3.0 co-simulation with FMPy in Python: importing FMUs, stepping the solver, coupling models, and debugging the loop.
Digital Twin Information Models: AAS vs DTDL vs OPC UA
A 2026 comparison of digital twin information models - Asset Administration Shell, DTDL, and OPC UA: semantics, tooling, interoperability, and a decision matrix.
Pharma Manufacturing Digital Twin: Reference Architecture
A vendor-neutral 2026 reference architecture for a pharma manufacturing digital twin: PAT data, GMP validation, batch genealogy, and the closed control loop.
Base Editing Explained: Single-Base CRISPR Therapeutics
Base editing rewrites a single DNA letter without cutting the double helix. How cytosine and adenine base editors work, their off-target limits, and 2026 clinical use.